Allied Biotech (1780) Stock Overview
Manufactures and sells carotenoids worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
1780 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Allied Biotech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$21.75 |
| 52 Week High | NT$21.90 |
| 52 Week Low | NT$15.30 |
| Beta | -0.11 |
| 1 Month Change | 23.93% |
| 3 Month Change | 23.58% |
| 1 Year Change | 28.32% |
| 3 Year Change | 55.91% |
| 5 Year Change | 23.93% |
| Change since IPO | 22.19% |
Recent News & Updates
Recent updates
Is Allied Biotech Corporation (GTSM:1780) A Good Dividend Stock?
Apr 16
These 4 Measures Indicate That Allied Biotech (GTSM:1780) Is Using Debt Reasonably Well
Mar 05Allied Biotech (GTSM:1780) Has Compensated Shareholders With A Respectable 49% Return On Their Investment
Jan 24Is Allied Biotech Corporation (GTSM:1780) At Risk Of Cutting Its Dividend?
Jan 03A Look At The Intrinsic Value Of Allied Biotech Corporation (GTSM:1780)
Dec 13
Is Allied Biotech (GTSM:1780) A Risky Investment?
Nov 25Shareholder Returns
| 1780 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 10.1% | 7.1% | 0.7% |
| 1Y | 28.3% | 4.7% | 21.9% |
Return vs Industry: 1780 exceeded the TW Biotechs industry which returned 4.7% over the past year.
Return vs Market: 1780 exceeded the TW Market which returned 21.9% over the past year.
Price Volatility
| 1780 volatility | |
|---|---|
| 1780 Average Weekly Movement | 5.3% |
| Biotechs Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1780 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1780's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Qing Hui Lin | www.altratene.com |
Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutein, a carotenoid that provides a range of green leafed vegetables, such as spinach, kale, broccoli, and egg yolks.; and Nano Coenzyme Q10, an antioxidant, which is used in the transformation of energy in the body.
Allied Biotech Corporation Fundamentals Summary
| 1780 fundamental statistics | |
|---|---|
| Market cap | NT$2.09b |
| Earnings (TTM) | NT$48.76m |
| Revenue (TTM) | NT$804.46m |
Is 1780 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1780 income statement (TTM) | |
|---|---|
| Revenue | NT$804.46m |
| Cost of Revenue | NT$523.35m |
| Gross Profit | NT$281.11m |
| Other Expenses | NT$232.35m |
| Earnings | NT$48.76m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 34.94% |
| Net Profit Margin | 6.06% |
| Debt/Equity Ratio | 87.7% |
How did 1780 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 18:56 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Allied Biotech Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.